
Julie Ozier, MHL, CIP, CHRC
Julie Ozier has over 20 years of experience in the human research protections and research compliance area. At Advarra, she has operational oversight of the IRB Review/Regulatory team and provides senior regulatory leadership. Previously, Ozier served as the Director of the Human Research Protections Program at Vanderbilt University and Medical Center. Additionally, she also served as a site visitor and council member for AAHRPP and is active in the HRPP community. Ozier has a Master’s in Health Law and is a Certified IRB Professional and Certified in Healthcare Research Compliance.
Latest Posts by Julie Ozier

What is a Quality IRB Review?
Metrics in general are one of the ways we can gauge how well a program...
Read More...
Your Guide to sIRB Mandates
In the past few years, new regulations and policies have been announced and implemented to...
Read More...
FDA’s September 2022 NPRMs: What They Mean for Academia and Industry
On September 28, 2022, the Food and Drug Administration (FDA) released two Notices of Proposed...
Read More...
Why do Funding and Legal Structure Matter in Decentralized Clinical Trials?
Optimizing clinical trial access for potential patients is a critical goal for researchers and sponsors....
Read More...
What do I do About Incidental Findings in Research?
An incidental finding is a “finding” or result from an intervention or test that uncovers...
Read More...